Click the icons below to search through Pioneer’s reports and documents.
|Date added||July 26, 2018|
|Category||Health Care, Health Care Policy (MA), Life Sciences, Price Transparency, White Papers|
Author: WIlliam Smith
Date: July 26, 2018
This report finds that most new drug pricing transparency laws do not lower consumer out-of-pocket costs, and that expensive and onerous compliance rules would likely put upward pressure on prices. The report reviews recent New England legislative attempts to reduce costs by requiring the disclosure of wholesale drug prices and other information about industry pricing practices. The report argues that most of these new laws will not reduce consumer prices because out-of-pocket expenses are generally unrelated to wholesale drug costs.